- Home
- CMMB vs OM Comparison
CMMB vs OM Comparison
Compare CMMB & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- OM
- Stock Information
- Founded
- CMMB 2004
- OM 2003
- Country
- CMMB Israel
- OM United States
- Employees
- CMMB N/A
- OM N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CMMB Health Care
- OM Health Care
- Exchange
- CMMB Nasdaq
- OM Nasdaq
- Market Cap
- CMMB 27.0M
- OM 31.8M
- IPO Year
- CMMB N/A
- OM 2020
- Fundamental
- Price
- CMMB $1.58
- OM $0.90
- Analyst Decision
- CMMB Strong Buy
- OM Buy
- Analyst Count
- CMMB 3
- OM 4
- Target Price
- CMMB $5.67
- OM $4.38
- AVG Volume (30 Days)
- CMMB 99.6K
- OM 962.6K
- Earning Date
- CMMB 11-14-2024
- OM 11-06-2024
- Dividend Yield
- CMMB N/A
- OM N/A
- EPS Growth
- CMMB N/A
- OM N/A
- EPS
- CMMB N/A
- OM N/A
- Revenue
- CMMB N/A
- OM $114,729,000.00
- Revenue This Year
- CMMB N/A
- OM N/A
- Revenue Next Year
- CMMB N/A
- OM $11.81
- P/E Ratio
- CMMB N/A
- OM N/A
- Revenue Growth
- CMMB N/A
- OM N/A
- 52 Week Low
- CMMB $0.42
- OM $0.44
- 52 Week High
- CMMB $2.55
- OM $6.37
- Technical
- Relative Strength Index (RSI)
- CMMB 60.64
- OM 73.46
- Support Level
- CMMB $1.44
- OM $0.80
- Resistance Level
- CMMB $1.90
- OM $0.93
- Average True Range (ATR)
- CMMB 0.13
- OM 0.08
- MACD
- CMMB 0.04
- OM 0.04
- Stochastic Oscillator
- CMMB 67.49
- OM 89.20
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.